Polymeric Nanocarriers for Enhanced Blood-Brain Barrier Permeation in Neurological Drug Delivery
- 1 February 2026
- journal article
- Published by Bentham Science Publishers Ltd. in Micro and Nanosystems
- Vol. 18 (1) , 1-14
Abstract
The blood-brain barrier (BBB) serves as a formidable obstacle to the treatment of neurological disorders by restricting the passage of therapeutic agents into the central nervous system (CNS). Polymeric nanocarriers have emerged as innovative tools to enhance drug delivery across the BBB, improving the bioavailability and efficacy of treatments for various neurological diseases. This review explores the challenges associated with BBB permeability and highlights recent advances in polymeric nanocarrier design. Key strategies such as surface modification, ligand conjugation, and stimuli-responsive carriers are discussed to optimize BBB penetration. Furthermore, this review examines the therapeutic potential of nanocarrier-based approaches for treating neurodegenerative disorders, brain tumors, and stroke. By leveraging nanotechnology, polymeric nanocarriers offer a promising avenue to overcome BBB-related drug delivery limitations and advance CNS therapeutics.Keywords
This publication has 112 references indexed in Scilit:
- Intranasal Delivery of Functionalized Polymeric Nanomaterials to the BrainAdvanced Healthcare Materials, 2022
- Role of Insulin Resistance in the Alzheimer's Disease ProgressionNeurochemical Research, 2020
- Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flowBioengineering & Translational Medicine, 2019
- Into rather unexplored terrain—transcellular transport across the blood–brain barrierGlia, 2016
- pH‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agentsWIREs Nanomedicine and Nanobiotechnology, 2016
- Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug DeliveryPharmaceutical Research, 2013
- Nanocarriers’ entry into the cell: relevance to drug deliveryCellular and Molecular Life Sciences, 2009
- Alzheimer's Disease: From Pathology to Therapeutic ApproachesAngewandte Chemie International Edition, 2009
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- NEUROPROTECTIVE EFFECTS OF CURCUMIN2007